Posted on 11/6/20
Sarepta Therapeutics Announces Recent Corporate Developments
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for . . .
Posted on 11/6/20
Ziopharm Oncology Provides Corporate Update
BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced its financial results for the third quarter ended September 30, 2020 and . . .
Posted on 11/6/20
Adicet Provides Business Update
MENLO PARK, Calif. and BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta . . .
Posted on 11/5/20
Cigna Reports Third Quarter 2020 Performance
Global health services company Cigna Corporation (NYSE: CI) today reported solid third quarter 2020 performance led by strong execution by its Evernorth segment."In these dynamic and . . .
Posted on 11/5/20
Akebia Reports Third Quarter 2020 Financial Results
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, today reported financial results for . . .
Posted on 11/5/20
Stealth BioTherapeutics Reports Third Quarter 2020 Financial Results
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today reported . . .
Posted on 11/5/20
Merrimack Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced its third quarter 2020 financial results for the period ended September 30, 2020.“We are pleased that both . . .
Posted on 11/5/20
Alnylam Pharmaceuticals Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter 2020 and reviewed recent . . .
Posted on 11/5/20
Magenta Therapeutics Reports Recent Business Highlights and Third Quarter Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today reported . . .
Posted on 11/5/20
Aldeyra Therapeutics Announces Third-Quarter 2020 Financial Results and Provides Corporate Update
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives . . .
Posted on 11/5/20
AVROBIO Reports Third Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today reported . . .
Posted on 11/5/20
Diversified Healthcare Trust Announces Third Quarter 2020 Results
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter and nine months ended September 30, 2020."While the senior living industry . . .
Posted on 11/5/20
Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today reported . . .
Posted on 11/5/20
Bicycle Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
CAMBRIDGE, England, & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycles®) . . .
Posted on 11/5/20
Sage Therapeutics Announces Third Quarter 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with . . .
Posted on 11/5/20
Concert Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Company Update
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2020.“Our focus this year has been to advance our proprietary . . .
Posted on 11/5/20
Karuna Therapeutics Reports Third Quarter 2020 Financial Results and Provides General Business Update
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with . . .
Posted on 11/5/20
Modalis Therapeutics Reports Third Quarter 2020 Financial Results and Operational Highlights
TOKYO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Modalis Therapeutics Corporation (TOKYO: 4883), a leading company developing innovative products for the treatment of rare genetic diseases utilizing its proprietary CRISPR-GNDM epigenetic . . .
Posted on 11/5/20
Radius Health Third Quarter 2020 Operating Results
WALTHAM, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today reported its financial and operating results for the third quarter ended September . . .
Posted on 11/5/20
Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update
WOBURN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today . . .
Posted on 11/5/20
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare . . .
Posted on 11/5/20
Imara Reports Third Quarter 2020 Financial Results and Business Highlights
BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering . . .
Posted on 11/5/20
EyePoint Pharmaceuticals Reports Third Quarter 2020 Financial Results and Highlights Recent Corporate Developments
WATERTOWN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced . . .
Posted on 11/5/20
X4 Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from . . .
Posted on 11/5/20
Intellia Therapeutics Announces Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both . . .
Boston
